[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2575-2576]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01513]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Microgenics
Corporation Thermo Fisher Scientific
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before March 11, 2019. Such
persons may also file a written request for a hearing on the
application on or before March 11, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
October 23, 2018, Microgenics Corporation/Thermo Fisher Scientific
located at 46500 Kato Rd., Fremont, California 94538, applied to be
registered as an importer of the below listed basic classes of
controlled substance listed in schedules I and II.
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................. 1235......... I
[[Page 2576]]
Mephedrone (4-Methyl-N-methylcathinone)... 1248......... I
Gamma Hydroxybutyric Acid................. 2010......... I
Methaqualone.............................. 2565......... I
Mecloqualone.............................. 2572......... I
2-(1-(4-fluorobenzyl)-1Hindazole-3- 7021......... I
carboxamido)-3-methylbutanoate.
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan- 7023......... I
2-yl)-1-pentyl-1H-indazole-3-carboxamide).
AB-CHMINACA (N-(1-amino-3-methyl-1- 7031......... I
>oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide.
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032......... I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033......... I
indazole-3-carboxamido)-3-
methylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035......... I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl- 7048......... I
1H-indazole-3-carboxamide.
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) 7201......... I
indole).
Lysergic acid diethylamide................ 7315......... I
Marihuana................................. 7360......... I
Tetrahydrocannabinols..................... 7370......... I
3,4-Methylenedioxyamphetamine............. 7400......... I
3,4-Methylenedioxy-N-ethylamphetamine..... 7404......... I
3,4-Methylenedioxymethamphetamine......... 7405......... I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine 7518......... I
(2C-I).
MDPV (3,4-Methylenedioxypyrovalerone)..... 7535......... I
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538......... I
methoxybenzyl) ethanamine (25I-NBOMe).
Butylone.................................. 7541......... I
Pentylone................................. 7542......... I
alpha-pyrrolidinopentiophenone ([alpha]- 7545......... I
PVP).
Normorphine............................... 9313......... I
AH-7921 (3,4-dichloro-N-[(1- 9551......... I
dimethylamino)cyclohexylmethyl]benzamide)
).
Acetylmethadol............................ 9601......... I
Alphamethadol............................. 9605......... I
Ketobemidone.............................. 9628......... I
Noracymethadol............................ 9633......... I
Para-Fluorofentanyl....................... 9812......... I
3-Methylfentanyl.......................... 9813......... I
Alpha-methylfentanyl...................... 9814......... I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821......... I
yl)-N-phenylacetamide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825......... I
phenylacetamide.
3-Methylthiofentanyl...................... 9833......... I
Cyclopropyl Fentanyl...................... 9845......... I
Fentanyl related-compounds as defined in 9850......... I
21 CFR 1308.11&h).
Amphetamine............................... 1100......... II
Methamphetamine........................... 1105......... II
Methylphenidate........................... 1724......... II
Amobarbital............................... 2125......... II
Pentobarbital............................. 2270......... II
Secobarbital.............................. 2315......... II
Phencyclidine............................. 7471......... II
Cocaine................................... 9041......... II
Codeine................................... 9050......... II
Dihydrocodeine............................ 9120......... II
Oxycodone................................. 9143......... II
Hydromorphone............................. 9150......... II
Ecgonine.................................. 9180......... II
Hydrocodone............................... 9193......... II
Levorphanol............................... 9220......... II
Meperidine................................ 9230......... II
Meperidine intermediate-B................. 9233......... II
Methadone................................. 9250......... II
Dextropropoxyphene, bulk (non-dosage 9273......... II
forms).
Morphine.................................. 9300......... II
Thebaine.................................. 9333......... II
Levo-alphacetylmethadol................... 9648......... II
Oxymorphone............................... 9652......... II
Carfentanil............................... 9743......... II
Tapentadol................................ 9780......... II
Fentanyl.................................. 9801......... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
feasibility studies for new products and cross reactivity studies for
existing products. The products will serve as raw materials for InVitro
Diagnostic quantitative assay.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01513 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P